Showing results (41-50 of 88) with videos related to

Sort By:
Pageof 9
Plos One|December 31, 2013
Markers of T cell infiltration and function associate with favorable outcome in vascularized high-grade serous ovarian carcinomaKatelin N Townsend, Jaeline E Spowart, Hassan Huwait, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|August 5, 2025
A broad range of antiphospholipid IgM are elevated across different multiple sclerosis clinical phenotypesKaya Frese, Pal Patel, Pierre Becquart, et al.
International Journal of Molecular Sciences|May 5, 2011
Claudin 4 Is differentially expressed between ovarian cancer subtypes and plays a role in spheroid formationKristin L M Boylan, Benjamin Misemer, Melissa S De Rycke, et al.
The Journal of Pathology|May 19, 2011
Loss of BAF250a (ARID1A) is frequent in high-grade endometrial carcinomasKimberly C Wiegand, Anna F Lee, Osama M Al-Agha, et al.
Cancer|July 2, 2011
Comparison of clinical schemas and morphologic features in predicting Lynch syndrome in mutation-positive patients with endometrial cancer encountered in the context of familial gastrointestinal cancer registriesPaul Ryan, Anna Marie Mulligan, Melyssa Aronson, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 28, 2012
BRCA1 and BRCA2 mutations correlate with TP53 abnormalities and presence of immune cell infiltrates in ovarian high-grade serous carcinomaJessica N McAlpine, Henry Porter, Martin Köbel, et al.
BMC Cancer|December 17, 2009
HER2 overexpression and amplification is present in a subset of ovarian mucinous carcinomas and can be targeted with trastuzumab therapyJessica N McAlpine, Kimberly C Wiegand, Russell Vang, et al.
American Journal of Clinical Pathology|October 21, 2010
Nectin 4 overexpression in ovarian cancer tissues and serum: potential role as a serum biomarkerMelissa S Derycke, Stefan E Pambuccian, C Blake Gilks, et al.
Genes, Chromosomes & Cancer|March 5, 2008
Amplification of 11q13 in ovarian carcinomaLindsay A Brown, Steve E Kalloger, Melinda A Miller, et al.
The Journal of Pathology. Clinical Research|August 4, 2017
A predictive analysis of the SP120 and 10D7G2 antibodies for human equilibrative nucleoside transporter 1 (hENT1) in pancreatic ductal adenocarcinoma treated with adjuvant gemcitabineSteve E Kalloger, Maziar Riazy, Basile Tessier-Cloutier, et al.
Pageof 9